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This study revealed the
severity of cerebral micro-
bleeds (CMBs) in radiation-
induced brain necrosis (RN)
and the cognitive impact of
CMBs in patients with RN.
We found that in patients
undergoing radiation ther-
apy, CMBs presented most
commonly in temporal lobes.
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http://dx.doi.org/10.1016/j.ijrobp.2015.11.037Purpose: Radiation therapy for patients with nasopharyngeal carcinoma (NPC) may
be complicated with radiation-induced brain necrosis (RN), resulting in deteriorated
cognitive function. However, the underlying mechanism of this phenomenon remains
unclear. This study attempts to elucidate the association between cerebral microbleeds
(CMBs) and radiation necrosis and cognitive dysfunction in NPC patients treated with
radiation therapy.
Methods and Materials: This cross-sectional study included 106 NPC patients who
were exposed to radiation therapy (78 patients with RN and 28 without RN). Sixty-
six patients without discernable intracranial pathology were included as the control
group. CMBs were confirmed using susceptibility-weighted magnetic resonance imag-
ing. Cognitive function was accessed using Montreal Cognitive Assessment. Patients
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Shen et al. International Journal of Radiation Oncology  Biology  Physics1114CMBs was significantly
associated with volume of
brain necrosis and cognitive
dysfunction.Results: Seventy-seven patients (98.7%) in the RN group and 12 patients (42.9%) in
the non-RN group had at least 1 CMB. In contrast, only 14 patients (21.2%) in the
control group had CMBs. In patients with a history of radiation therapy, CMBs most
commonly presented in temporal lobes (76.4%) followed by cerebellum (23.7%). Pa-
tients with RN had more temporal CMBs than those in the non-RN group (37.7  51.9
vs 3.8  12.6, respectively; P<.001). The number of temporal lobe CMBs was predic-
tive for larger volume of brain necrosis (P<.001) in multivariate linear regression anal-
ysis. Although cognitive impairment was diagnosed in 55.1% of RN patients, only
7.1% of non-RN patients sustained cognitive impairment (P<.001). After adjusting
for age, sex, education, period after radiation therapy, CMBs in other lobes, and RN
volume, the number of temporal CMBs remained an independent risk factor for cogni-
tive dysfunction (odds ratio [OR]: 1.03; 95% confidence interval [CI]: 1.01-1.04;
PZ.003).
Conclusions: CMBs is a common radiological manifestation in NPC patients with
RN. The number of temporal CMBs is independently associated with increased likeli-
hood of cognitive dysfunction in patients with RN.  2016 The Authors. Published by
Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Nasopharyngeal carcinoma (NPC) is a prevalent disease in
southern China (1), especially in Guangdong province.
Radiation therapy is the standard radical treatment for NPC
but may cause transient as well as long-term complications
(2). Radiation-induced brain necrosis (RN) is one of the
severe complications that potentially leads to cognitive
dysfunction, seizure, headache, and limb paralysis. The
incidence rate of RN has been demonstrated to directly
correlate with the modality of radiation therapy and was
suggested in previous studies to have lower occurrences in
patients treated with intensity modulated radiation therapy
(IMRT) (3, 4). According to our previous study results,
NPC patients with RN may present significant cognitive
impairment compared with those without RN (5). In
contrast to other complications that have more compelling
presentations and therefore are largely reported in studies,
cognitive impairment has a subtle pathophysiological pre-
sentation that has not been adequately appreciated but has a
marked impact on the irradiated patient’s subsequent
quality of life (5-7). However, despite clear indications of
association between RN and cognitive impairment, the
underlying mechanism has yet to be established.
Cerebral microbleeds (CMBs), defined as hemorrhagic
microvascular lesions or microangiopathy in the brain, are
well known to progressively affect the function of the
neurovascular unit and result in cognitive dysfunction
(8-10). Werring et al (11) retrospectively analyzed 55 pa-
tients with suspected stroke or transient ischemic attacks
and revealed independent association between CMBs and
cognitive dysfunction, regardless of the extent of white
matter changes of presumed ischemic origin or the presence
of ischemic stroke. From our clinical experience, CMBs are
frequently detected in patients with RN. Based on these
observations, we hypothesized that CMBs might beassociated with cognitive impairment in RN patients. We
initiated a cross-sectional study to evaluate the prevalence
and severity of CMBs in NPC patients after radiation
therapy by susceptibility-weighted magnetic resonance
imaging (SWI). Results were compared with those for 66
individuals without a history of radiation therapy or trau-
matic brain injury (control group). We also explored the
relationship among CMBs, volume of brain necrosis, and
cognitive function in patients with RN.Methods and Materials
Patient population
We prospectively included patients who underwent radia-
tion therapy at least 12 months prior to admission within
the neurology department of our hospital between February
2012 and January 2014. Patient baseline information was
retrospectively collected from chart reviews. Patients with
the following criteria were excluded from the study: those
with (1) a present diagnosis of intracranial cancer metas-
tases; or a history of (2) cerebrovascular disease or Alz-
heimer disease; (3) hypertension and diabetes; (4) other
neurological diseases accompanied by cognitive dysfunc-
tion; and (5) severe dementia or an altered level of con-
sciousness. In the same period, inpatients within the same
department without radiation therapy who did not match
any exclusion criteria were recruited as controls.
The diagnosis of RN was defined as a lesion of high
intensity on T2-weighted images and a lesion of enhance-
ment on post-contrast images, particularly with “soap
bubble” or “Swiss cheese” enhancement (12, 13). Cognitive
function was evaluated by Montreal Cognitive Assessment
(MoCA) scale (Chinese version); CMB-related information
was assessed by SWI; and the volume of RN was measured
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including age, sex, educational background, radiation dose,
radiation technique, and post-radiation therapy follow-up
interval were also collected. This study was approved by
the institutional ethics review board of our hospital.
Informed consent was obtained from all enrolled patients.
Brain imaging
Magnetic resonance imaging (MRI) was performed using a
1.5-T whole-body MRI system (Gyroscan Intera; Philips,
Aachen, Germany), with an 8-channel phased-array head
coil. Imaging protocol included the following pulse se-
quences: (1) axial T2-weighted imaging (20 slices; field of
viewZ 250 mm; slice thicknessZ 5 mm; gapZ 1.0 mm,
repetition time [TR] Z 4400 ms; TE Z 110 ms; flip
angle Z 90); (2) axial SWI (100 slices; field of
view Z 250 mm; voxel size Z 1  1  1.2 mm;
TEZ 40 ms; TRZ 35 ms; flip angleZ 15). SWI images
were constructed by multiplying magnitude images with
filtered phase images to enhance the susceptibility effect,
and then a minimum-intensity projection reconstruction
was performed with a slice thickness of 6 mm and an
interslice gap of 1 mm. (3) Axial T1-weighted imaging (20
slices; field of view Z 250 mm; slice thickness Z 5 mm;
gap Z 1.0 mm; TR Z 540 ms; TE Z 15 ms; flip
angleZ 70); (4) coronal T2-weighted FLAIR imaging (18
slices; slice thickness Z 5 mm; gap Z 1.5 mm;
TE Z 180 ms; TR Z 11,000 ms; TI Z 2800 ms); and (5)
axial T1-weighted enhancement scans (Gd-EDPA; 0.2 mL/
kg [Magnevist, Bayer Schering Pharma AG, Berlin, Ger-
many]) use the same scan parameters as for T1-weighted
imaging. CMBs were defined as hypointense homoge-
neous foci of at least 10 mm in diameter demonstrated on
SWI sequences; symmetrical hypointensities in the globus
pallidus and flow voids from cortical vessels were dis-
regarded. Images were interpreted by a neuroradiologist
who was blinded to the clinical diagnosis.
Cognitive function evaluation
Patient cognitive function at follow-up was assessed by
using the MoCA scale (Chinese version), which consists of
7 different cognitive domains: visuospatial and executive
abilities, naming, attention, language, abstraction, delayed
recall memory, and orientation (14). Each domain has a
maximum score range from 2 to 6, and the final score of
MoCA was defined as the total score of all 7 domains. A
total score less than 26 was determined to indicate cogni-
tive dysfunction in our study.
Statistical analysis
Continuous variables were described as means and standard
deviations, whereas categorical variables were presented in
numbers and percentages. Analysis of variance (ANOVA)and post hoc tests were used to detect differences in age,
post-radiation therapy interval, radiation dose, and number
of microbleeds between groups, whereas Wilcoxon and c2
tests were used for comparison of educational background
and sex, respectively. Cognitive function was divided into 2
categories, normal cognitive function (MoCA  26) and
cognitive dysfunction (MoCA < 26). All variables were
included in multiple linear regression and multivariate
logistic regression models to adjust for confounding fac-
tors. All P values were reported as 2-sided with significance
level defined as a P value of <.05. All statistical analysis
was performed using Stata version 13.0 software (Stata
Statistical Software, College Station, TX).
Results
Patient population and baseline demographics
After we applied inclusion and exclusion criteria, a total of
172 patients were identified and included in our study. In
172 patients, 106 patients (61.6%) underwent radiation
therapy and were further divided into the RN group (nZ78)
and the non-RN group (nZ28). Another 66 patients were
included as the control group to fully appreciate the effect
of radiation therapy on the number of CMBs, and their
diagnoses were as follows: nZ18 cervical spondylosis,
nZ13, facial nerve palsy, nZ11 polymyositis, nZ10
myasthenia gravis, nZ9 mild depression, and nZ5
Guillain-Barre syndrome. A detailed flow-chart of partici-
pant selection is shown in Figure 1.
As shown in Table 1, age at diagnosis and education
background were similar across comparison groups. No
significant differences were found in terms of proportion of
IMRT, radiation dose, period of time since radiation ther-
apy, and the proportion of those receiving chemotherapy in
the RN group compared to that in the non-RN group.
However, more male patients than controls were treated
with radiation therapy (PZ.002), with the RN group hav-
ing the highest proportion of male patients (nZ57; 73.1%).
Cerebral microbleeds
At least 1 CMB was found in 77 patients (98.7%) in the RN
group, in 12 patients (42.9%) in the non-RN group, and in
14 patients (21.2%) in the control group. For patients who
previously underwent radiation therapy, CMBs occurred
most frequently (76.4%) in temporal lobes (Fig. 2), fol-
lowed by cerebellum (23.7%), basal ganglia (15.8%), oc-
cipital lobe (10.5%), brain stem (9.2%), and frontal lobe
(3.9%). To clarify whether radiation therapy was associated
with a higher propensity for CMBs, we compared the
number of CMBs in patients with a history of radiation
therapy with that of patients without a history of radiation
therapy. Results showed that patients with radiation therapy
presented with more CMBs (29.8  48.0 vs 0.7  2.1,
respectively; P<.001) than their counterparts. To account
Feb 2012 to Jan 2014,
      576 inpatients
129 NPC patients with 
              RT
106 NPC patients
  23 Excluded after
applying inclusion and
   exclusion criteria
447 patients with other
          diseases
  381 Excluded after
applying inclusion and
   exclusion criteria
66 patients with other
        diseases
78 in RN group 28 in non-RN group 66 in control group
Fig. 1. Flow chart of study cohort selection. Abbreviations: NPCZ nasopharyngeal cancer; RNZ radiation-induced brain
necrosis.
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radiation therapy groups, we further stratified our data by
sex and found that the association between radiation ther-
apy and CMBs was still significant in each sex stratum
(males, P<.001; females, PZ.003). We also compared the
differences between numbers of CMBs in the control group
with those in the non-RN group but failed to observe a
difference in the number of CMBs in each individual pa-
tient between those 2 groups (0.7  2.1 vs 4.2  12.7,
respectively; PZ.156), which suggested that RN was a
stronger indicator of CMBs than radiation therapy, as we
have shown that the development of CMBs is associated
with RN but not necessarily with radiation therapy. In
addition, we observed significant differences between
numbers of CMBs in temporal lobes in RN patients
compared to those in non-RN patients (37.7  51.9 vs
3.8  12.6, respectively P<.001). Conversely, the numberTable 1 Comparison between patient baseline characteristics in dif
Parameter Control group (NZ66) No
Age (SD) (y) 48.8 (15.2)
Sex
Males (%) 30 (45.5)
females (%) 36 (54.5)
Education
Primary school (%) 4 (6.1)
High school (%) 34 (51.5)
College or above (%) 28 (42.4)
Post-RT interval (SD) (y) -
Radiation dose (Gy) -
IMRT (%) -
Chemotherapy (%) -
Abbreviations: CMBs Z cerebral microbleeds; IMRT Z intensity mo
RT Z radiation therapy; SD Z standard deviation.
* Significant variables (P<.050).of CMBs was not associated with RN in other locations of
the brain (PZ.169). Multivariate linear regression demon-
strated that higher numbers of temporal lobe CMBs was an
independent indicator (correlation coefficientZ 0.45; 95%
confidence interval [CI]: 0.26-0.64; P<.001) of larger vol-
ume of brain necrosis (Table 2) after adjusting for other
baseline demographic variables.Cognitive function
Within our study cohort, a total of 43 RN patients (55.1%)
and 2 non-RN patients (7.1%) were determined to be
cognitively impaired according to our study definition, and
all subjects in the control group were cognitively func-
tional. Patients in the RN group demonstrated lower MoCA
scores than non-RN and control groups (24.8  3.7 vsferent groups
n-RN group (nZ28) RN group (nZ78) P value
47.9 (7.2) 46.8 (8.6) .574
19 (67.9) 57 (73.1) .002*
9 (32.1) 21 (26.9)
1 (3.6) 10 (12.8) .323
15 (53.6) 41 (52.6)
12 (42.9) 27 (34.6)
5.3 (3.5) 6.5 (3.9) .167
70 (70-72) 71 (66-76) .428
9 (32.1) 29 (37.2) .819
21 (75.0) 61 (78.2) .728
dulated radiation therapy; RN Z radiation-induced brain necrosis;
Fig. 2. SWI of (A) a 55-year-old male patient without brain necrosis (RN) after radiation therapy. (B) A 50-year-old male
patient with brain necrosis. Arrow indicates cerebral microbleeds. Abbreviations: RN Z radiation-induced brain necrosis;
SWI Z susceptibility-weighted magnetic resonance imaging.
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respectively; P<.001). Interestingly, despite a lack of
radiological evidence of brain necrosis, patients in the non-
RN group sustained significantly lower MoCA scores than
the control group (28.1  2.0 vs 29.1  0.8, respectively;
PZ.018). A separate investigation of the effect of RN on
each domain of the MoCA score demonstrated that patients
in the RN group had lower scores in every domain except
for orientation than the non-RN group.Association between CMB and cognitive function
Using the multivariate logistic regression model to adjust
for age, sex, education, period after radiation therapy, and
brain necrosis volume, our data demonstrated that the
number of CMBs in the temporal lobe was an independentTable 2 Multivariate linear regression analysis of factors
associated with radiation-induced brain necrosis
Parameters
Correlation coefficient
(95% CI) P value
Age 1.17 (0.10-2.26) .033*
Sex (females vs males) 15.20 (34.05 to 3.66) .133
Years after radiation
therapy
0.76 (3.09 to 1.58) .522
Education
Primary school Reference
High school 7.85 (20.94 to 36.64) .590
College or above 12.96 (17.19 to 43.12) .396
CMBs in temporal lobes 0.45 (0.26 to 0.64) <.001*
CMBs in other lobes 0.14 (3.47 to 3.76) .937
Abbreviations: CMBs Z cerebral microbleeds.
* Significant variables (P<.050).risk factor for cognitive dysfunction (ORZ 1.03; 95% CI:
1.01-1.04; PZ.003). In addition, older age was also
significantly associated with higher risk of cognitive
dysfunction (OR Z 1.07; 95% CI: 1.00-1.14; PZ.041).
A detailed summary of results of univariate and multivar-
iate analyses is shown in Table 3. We further evaluated
potential predictive value of CMBs for each cognitive
domain, and the results showed that the number of CMBs in
the temporal lobe was significantly associated with lower
MoCA scores in visuospatial and executive abilities, lan-
guage, abstraction, and delayed recall memory. In contrast,
the number of CMBs in other lobes were only associated
with delayed recall memory (Table 4), although, in the non-
RN group, the association between temporal lobe CMBs
and cognitive impairment did not exist (univariate logistic
regression, PZ.113).
Discussion
Our study showed that CMB is a common manifestation in
patients with RN and is independently associated with an
increased likelihood of cognitive dysfunction. The rela-
tionship between CMBs and cognitive dysfunction has not
been described previously in RN patients but was widely
investigated and reported in Alzheimer disease (AD),
ischemic stroke, transient ischemic attack, vascular de-
mentia, and cerebral small vessel disease (15-18). The
underlying mechanism for increased risk of CMBs in RN
has not been clarified. Our previous study reported a high
prevalence of large vessel damage in RN (19). Furthermore,
the production of vascular endothelial growth factor
(VEGF) stimulated by radiation-induced local hypoxia
has been shown to increase the permeability of the blood-
brain barrier (20). Taken together, these results implied a
Table 3 Univariate and multivariate logistic regression analysis on factors associated with cognitive dysfunction
Parameters
Univariate analysis Multivariate analysis
OR (95% CI) P value OR (95% CI) P value
Age 1.01 (0.98-1.05) .354 1.07 (1.00-1.14) .041*
Sex
Male Reference Reference
Females 0.49 (0.23-1.04) .063 0.98 (0.34-2.81) .976
Period after RT 1.07 (0.96-1.19) .208 1.07 (0.94-1.22) .319
Education
Primary school Reference Reference
High school 0.35 (0.11-1.07) .066 0.31 (0.06-1.59) .160
College or above 0.39 (0.12-1.23) .108 0.65 (0.13-3.40) .613
Temporal CMBs 1.04 (1.02-1.06) <.001* 1.03 (1.01-1.04) .003*
CMB in other lobes 1.12 (0.96-1.30) .166 0.81 (0.62-1.06) .120
Volume of RN (cm3) 1.03 (1.01-1.04) <.001* 1.01 (1.00-1.02) .154
Abbreviations: CMBs Z cerebral microbleeds; RN Z radiation-induced brain necrosis; RT Z radiation therapy.
* Significant variables (P<.050).
Shen et al. International Journal of Radiation Oncology  Biology  Physics1118vessel-related pathogenesis in RN that potentially leads to
increased risk of CMBs in these patients and eventually
resulted in impaired cognitive function.
Increasing evidence suggests that the anatomic distri-
bution of CMBs varies by cause. Our data demonstrated a
predominance of CMBs in temporal location, which differs
from the distribution of CMB locations in demented pa-
tients with other causes (15, 21-23). Previous reports have
shown that lobar CMBs were related to cognitive impair-
ment in cerebral amyloid angiopathy (16, 24). The Sun-
nybrook dementia study reported occipital predominance of
CMBs in AD (15). On the other hand, deep CMBs in the
basal ganglia were closely attributed to hypertensive
microangiopathy (23). The higher occurrence of CMBs in
the temporal lobe in our study cohort may be related to
increased susceptibility of temporal lobes injuries induced
by vicinity of radiation for NPC. In these patients, although
the maximum doses delivered to the brainstem and spinal
cord were generally well maintained by IMRT, the
maximum doses deposited in the temporal lobes may have
a higher propensity for exceeding conventional limits (25).
This explanation is further endorsed by previous report of
the association between the T stage of NPC and temporal
lobe injury in IMRT patients, where a larger tumor exten-
sion indicated a compromise in planning dose for the
temporal lobe. The reported incidence rate is between 4.8%
to 16%, and may gradually increase over time after IMRT
(4, 26, 27).
Our previous study also found that cognitive function
was negatively correlated with the volume of RN. In the
current study, after we adjusted for possible confounding
factors including brain necrosis volume, age, and educa-
tion, the number of CMBs still stood out as a significant
predictor of cognitive dysfunction. Of note, despite
demonstrating a significant influence on cognitive function
in the univariate analysis, the volume of RN was not found
to be significant in multivariate analysis. Our results
demonstrated that CMBs have a higher predictive value ofcognitive decline in RN patients than in RN volume. We
also demonstrated that temporal CMBs numbers was pre-
dictive of certain domains in MoCA score but not others.
The inequitable effect of temporal CMBs on each domain
highlights the fact that various cognitive functions are
mediated by different brain regions. Further studies are
warranted to focus on the different cognitive impairments
associated with various CMBs to fully appreciate the effect
of CMBs on cognitive impairment in RN patients.
Our study has several limitations that need to be
addressed for accurate interpretation of our results. First, the
study used a cross-sectional design, which may be inade-
quate to describe the natural history and progression of
CMBs in this population. Although an independent associ-
ation was found between CMBs and cognitive dysfunction, a
causal relationship of CMB as the underlying mechanism of
cognitive function in RN cannot be established. Next, the
patients in the control group harbored diagnosed neurolog-
ical pathologies, which might indirectly have affected the
assessment of cognitive function. We attempted to address
this by prudently selecting our exclusion criteria and
including only patients with clinical courses that were
known to be unrelated to changes in cognitive function. In
addition, some confounding factors such as the APOE gene,
smoking, and lipid level have not been evaluated in our
study. In particular, we were unable to retrieve the detail
treatment planning information for all our recruited patients
and, thereby, were unable to generate dosimetric variables in
our study. We also included RN as an indirect indicator of
organ of interest dosimetry to compensate for the informa-
tion. The differences of sample size in each group also
increased the risk of mismatch of the risk factors for
cognitive dysfunction. A rigorous attempt to balance the
baseline characteristics was established; despite a difference
in sex distribution between outcome groups, we successfully
proved that the independent effect of CMBs on cognitive
function by analyzing the association of CMB and cognitive
function in each stratum of sex.
Table 4 Multivariate logistic regression on association of
risk factors and each domain within Montreal Cognitive
Assessment evaluation
Domains and
parameters
Correlation coefficient
(95% CI)
P
value
Visuospatial and executive abilities
Age 0.01 (0.03 to 0.01) .220
Sex (females vs
males)
0.03 (0.33 to 0.41) .832
Years after radiation
therapy
0.01 (0.03 to 0.06) .579
Education
Primary school Reference
High school 0.17 (0.40 to 0.73) .561
College or above 0.11 (0.48 to 0.70) .704
CMBs in temporal
lobes
0.01 (0.01 to 0.00) .001*
CMBs in other lobes 0.07 (0.00 to 0.14) .057
Necrosis volume
(cm3)
0.00 (0.01 to 0.00) .156
Naming
Age 0.01 (0.02 to 0.01) .335
Sex (females vs
males)
0.01 (0.19 to 0.21) .906
Years after radiation
therapy
0.00 (0.02 to 0.03) .887
Education
Primary school Reference
High school 0.05 (0.35 to 0.24) .716
College or above 0.06 (0.37 to 0.26) .726
CMBs in temporal
lobes
0.00 (0.00 to 0.00) .725
CMBs in other lobes 0.02 (0.02 to 0.06) .252
Necrosis volume
(cm3)
0.00 (0.00 to 0.00) .035*
Attention
Age 0.00 (0.02 to 0.01) .562
Sex (females vs
males)
0.03 (0.29 to 0.22) .801
Years after radiation
therapy
0.05 (0.08 to 0.01) .005*
Education
Primary school Reference
High school 0.02 (0.37 to 0.41) .932
College or above 0.22 (0.63 to 0.19) .295
CMBs in temporal
lobes
0.00 (0.00 to 0.00) .382
CMBs in other lobes 0.01 (0.04 to 0.05) .832
Necrosis volume
(cm3)
0.00 (0.01 to 0.00) .083
Language
Age 0.01 (0.02 to 0.00) .119
Sex (females vs
males)
0.05 (0.18 to 0.28) .665
Years after radiation
therapy
0.02 (0.05 to 0.01) .154
Education
Primary school Reference
High school 0.10 (0.24 to 0.45) .559
(continued)
Table 4 (continued )
Domains and
parameters
Correlation coefficient
(95% CI)
P
value
College or above 0.02 (0.38 to 0.34) .920
CMBs in temporal
lobes
0.00 (0.01 to 0.00) .001*
CMBs in other lobes 0.03 (0.01 to 0.07) .155
Necrosis volume
(cm3)
0.00 (0.00 to 0.00) .730
Abstraction
Age 0.00 (0.02 to 0.01) .612
Sex (females vs
males)
0.09 (0.14 to 0.31) .449
Years after radiation
therapy
0.01 (0.04 to 0.01) .356
Education
Primary school Reference
High school 0.01 (0.32 to 0.35) .939
College or above 0.05 (0.30 to 0.41) .766
CMBs in temporal
lobes
0.00 (0.01 to 0.00) <.001*
CMBs in other lobes 0.03 (0.01 to 0.07) .180
Necrosis volume
(cm3)
0.00 (0.00 to 0.00) .393
Delayed recall memory
Age 0.02 (0.05 to 0.02) .368
Sex (females vs
males)
0.10 (0.50 to 0.69) .743
Years after radiation
therapy
0.09 (0.16 to 0.02) .014*
Education
Primary school Reference
High school 0.11 (0.79 to 1.01) .805
College or above 0.27 (1.21 to 0.67) .571
CMBs in temporal
lobes
0.01 (0.02 to 0.01) <.001*
CMBs in other lobes 0.12 (0.01 to 0.23) .034*
Necrosis volume
(cm3)
0.01 (0.01 to 0.00) .057
Orientation
Age 0.00 (0.01 to 0.01) .552
Sex (females vs
males)
0.08 (0.05 to 0.21) .221
Years after radiation
therapy
0.01 (0.02 to 0.01) .400
Education
Primary school Reference
High school 0.04 (0.23 to 0.16) .692
College or above 0.19 (0.40 to 0.01) .062
CMBs in temporal
lobes
0.00 (0.00 to 0.00) .663
CMBs in other lobes 0.01 (0.04 to 0.01) .339
Necrosis volume
(cm3)
0.00 (0.00 to 0.00) .639
* Significant variables (P<.050).
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were independently associated with RN and post-treatment
cognitive dysfunction. With a cross-sectional design, we
cannot provide the temporal profile of the development of
Shen et al. International Journal of Radiation Oncology  Biology  Physics1120CMBs, thereby rendering our results insufficient to estab-
lish a causal relationship between CMBs and RN. However,
the clinical implications of our current findings cannot be
ignored. First, our results indirectly endorse the theory that
microvascular injury may be involved in the development
of RN. Therefore, interventions or medications targeted at
repairing microvascular injury are potentially effective in
prevention of RN, although further studies are warranted to
fully explore that possibility. Next, provided with the fact
that the number of CMBs can be easily assessed without
additional radiological exams except for follow-up MRIs, it
might pose as an optimal indicator of cognitive function
prognosis, and become useful in predicting RN develop-
ment. Personalized and accurate prediction of functional
outcomes helps physicians to provide better education and
preparation for patients and their families to cope with
anticipated decline of post-treatment cognitive function.
Finally, with the exploratory aim of this study, we hope to
see more future studies investigating the underlying causal
relationships among CMBs, RN, and cognitive function,
with a particular focus on longitudinal assessment of post-
radiation CMBs.
Conclusions
In conclusion, this study demonstrates that the number of
CMBs following radiation therapy is associated with
decline of cognitive function. This association is indepen-
dent of age, education, post-radiation interval, and volume
of brain necrosis. Our findings suggested the potential value
of CMBs for early diagnosis and treatment of cognitive
dysfunction in RN.
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